Vitamin Intervention for Stroke Prevention "VISP"


Phase 3 Results

Summary of Purpose

To determine whether reducing homocysteine levels with high-dose multivitamin therapy effectively decreases the risk of recurrent cerebral infarction or coronary heart disease in patients with a history of non-disabling cerebral infarction (NCDI).

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 19 September 2008.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics



  • National Institute for Neurological Disorders and Stroke, NIH

Trial Design

Double-blind, multicenter, randomized, controlled clinical trial


  • Elizabeth G. Sides Stroke Research Center Department of Neurology Wake Forest University School of Medicine, Medical Center Blvd Winston-Salem, North Carolina 27157-1078.